PullarTCapellHA. Interaction of indomethacin and warfarin. Br Med J1982; 184:108.
2.
Koch-WeserJSellersEM. Drug interactions with coumarin anticoagulants. New Engl J Med1971; 285:487–498 and 547–558.
3.
StarrKJPetrieJC. Drug interactions in patients on long term anticoagulant and antihypertensive adrenergic neuron-blocking drugs. Br Med J1972; 165:133–135.
4.
O'ReillyRA. In GilmanAGGoodmanLSGillmanA, eds. The Pharmacological Basis of Therapeutics, 6th Edition 1980.
5.
BackmanKABurkmamAM. Phenylbutazone-warfarin interaction in the dog. J Pharm Pharmac1975; 27:832–836.
6.
LewisRJTracerWFChanKK. Warfarinstereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest1974; 53:1607–1617.
7.
O'ReillyRATracerWFMotleyCHHowardW. Stereoselective interaction of phenylbutazone with (Rc/13c) warfarin pseudo-racematin in man. J Clin Invest1980; 65:745–753.
8.
McElnayJCD'ArcyPF. The effect of azapropazone on the binding of warfarin to human serum proteins. J Pharm Pharmacol1978;30 (Suppl): p73.
9.
Powel-JacksonPR. Interaction between azapropazone and warfarin. Br Med J1977; 174:1193–1194.
10.
GreenAEHartJFKornHETLeechH. Potentiation of warfarin by azapropazone. Br Med J1977; 1:1532.
11.
FrostHHessH. In HeisterRHofmanJF, eds. International Symposium on Inflammation, Freiburg in Breisgau Munich: Urbane and Schwarzenberg1966.
12.
MullerGZollingerW. In HeisterRHoffmanJF, eds. International Symposium on Inflammation, Freiburg in Breisgau Munich: Urbane and Schwarzenberg1966.
13.
VesselESPassanantiGTJohnsonAO. Failure of indomethacin and warfarin to interact in normal human volunteers. J Clin Pharmacol1975; 15:486–495.
14.
SchenkHKleinGHaralanbusIGoebelR. Coumarin therapy under the antirheumatic sulindac. Rheumatol1980; 39:102–108 (Trans).
15.
LaftinJPVesellES. Interaction between sulindac and warfarin: Different results in normal subjects and in an unusual patient with a potassium losing renal tubular defect. J Clin Path1979; 19:733–742.
16.
CarterSA. Potential effect of sulindac on response of prothrombin time to oral anticoagulants. Lancet1979; 2:698–699.
17.
RossJRYBeeleyL. Sulindac, prothrombin time and anticoagulants. Lancet1979; 2:1075.
18.
FranchimontPHeynenG. Comparative study of ibuprofen and dextropropoxyphene in scapulohumeral periarthritis following myocardial infarction. XIII International Congress of Rheumatology 1973;70–71.
19.
ThiloDNymanD. A study of the effects of antirheumatic drug ibuprofen (Brufen) on patients being treated with the oral anticoagulant phenprocoumarin (Marcoumar). J Int Med Res1974; 2:276–278.
20.
Bockhout-MussertMJLoeligerEA. Influence of ibuprofen on oral anticoagulation with phenprocoumarin. J Int Med Res1974; 2:279–283.
21.
DuckettF. The absence of effect of the antirheumatic drug ibuprofen and oral anticoagulation with phenprocoumarin. Curr Med Res Op1975; 3:556–557.
22.
SlatteryJTLevyG. Effect of ibuprofen on protein binding of warfarin in human serum. J Pharm Sc1977; 66:1060.
23.
RennerJAAbbrechtPH. Lack of interaction between ibuprofen and warfarin. Curr Ther Res1975; 18:862–871.
24.
GonchavesL. Influence of ibuprofen on haemostasis in patients on anticoagulant therapy. J Int Med Res1973; 1:180–183.
25.
MorbertGADuckertMWSisiPAirenH. Interaction study between phenprocoumarin and flurbiprofen. Curr Med Res Op1977; 5:26–31.
26.
YacobiALevyG. Effect of naproxen on protein binding of warfarin in human serum. Res Com In Chem Path Pharmacol1976; 15:369–372.
27.
SlatteryJTLevyGJainAMcMahonFG. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin. Clin Pharmacol Ther1979; 25:51–60.
28.
JainAMcMahonFGSlatteryJTLevyG. Effect of Naproxen on the steady state serum concentration and anticoagulant activity of warfarin. Clin Pharmacol Ther1979; 25:61–66.
29.
RubinAWarrickPWalenRLCharnishSMRidolfoASGrukerCM. Physiological disposition of fenoprofen in man III. Metabolism and protein binding of fenoprofen. J Pharmcol Exp Ther1972; 183:449–457.
30.
KrywanekHJBreddinK. Does diclofenac affect oral anticoagulant therapy and platelet aggregation. Med Welt1977; 28:1843–1845 (Trans).
31.
FitzgeraldDERussellJG. Voltard and warfarin, an interaction?Current Themes in Rheumatology1981, pp 26–27.
32.
SavitskyJPTerzakisTBinaPChiccorellFHaynesJ. Fenbufen-warfarin interaction in healthy volunteers. Clin Pharmacol Ther1980; 27:284.
33.
McElnayJCD'ArcyPF. Displacement of albumin-bound warfarin by anti-inflammatory agents in vitro. J Pharm Pharmacol1980; 32:709–711.
34.
TaylorMASancilioLFMatherP. Interaction between warfarin and anti-inflammatory drugs in rats. Fed Proc1979; 37 No 3 pt 1440.
35.
SerlinMJMossmanSSibeonRGBreckenridgeAH. The effect of diflunisal on the steady state pharmaco-dynamics and pharmacokinetics of warfarin. Proceeding of the BPS 17–19 Dec 1979.
36.
WhitsettTLBarryJPCzerwinskiAWHallWHHamptonJW. Tolmetin and warfarin: A clinical investigation to determine if interaction exists. In Tolmetin–A new non steroidal anti-inflammatory agent. WardJR, ed. Amsterdam: Excerpta Medica1975:160–167.
37.
ChatfleldDHGreenJNKeoJCTarrantMEWoodageTJ. Plasma protein binding and interaction studies with Benoxaprofen. Biochem Pharmacol1978; 27:887–900.
38.
SellersEMKoch-WeserJ. Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic and nalidixic acids. Clin Pharmac Ther;1970; 11:524–528.
39.
MinnFLZinnyMA. Zomepirac and warfarin: A clinical study to determine if interaction exists. J Clin Pharm1980;418–421.
40.
BullJMackinnonJ. Phenylbutazone and anticoagulant control. The Practitioner1975; 215:767–769.
41.
OrmeMBreckenridgeACookP. Warfarin and distalgesic interaction. Br Med J1976; 172:200.
42.
MeyersFHJawetzEGoldfeinA, eds. Review of Medical Pharmacology, 4th Edition. Lange1974.